Oriental Carbon and Chemicals (OCCL) Q4 18/19 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 18/19 earnings summary
2 Nov, 2026Executive summary
FY19 delivered profitable growth: revenue from operations rose 17% YoY, PAT increased 30%, and operating profit grew 25%; cost controls, capacity additions and stronger customer offtake supported results.
Insoluble Sulphur remained the core business, with ~80% of revenue from customers of five years or more and exports contributing 58% of revenue; Duncan Engineering returned to profit after six years.
Financial highlights
Standalone revenue from operations was ₹38,763.86 lakh, up 17% YoY; total revenue was ₹39,703.98 lakh versus ₹33,746.48 lakh.
PBT was ₹10,257.48 lakh versus ₹7,963.31 lakh; PAT was ₹7,374.14 lakh versus ₹5,675.01 lakh, up 30% as reported.
EBITDA was ₹12,941 lakh versus ₹10,383 lakh; reported margins benefited from attractive Sulphuric Acid realisations.
Consolidated revenue was ₹43,200.77 lakh versus ₹37,376.09 lakh; PAT was ₹7,652.08 lakh, including ₹138.93 lakh attributable to non-controlling interests.
Consolidated EPS was ₹73.45 from continuing operations; reported EPS including discontinued operations was also ₹73.45, versus ₹55.19 in FY18.
Outlook and guidance
Dharuhera brownfield expansion approved for 11,000 MTPA of Insoluble Sulphur in two 5,500-MTPA phases, at estimated cost ₹216 crore; phase one targeted for Q3 FY21.
Expansion plans also include increased Sulphuric Acid capacity, primarily to supply steam for expanded Insoluble Sulphur production.
Growth expected from customer capacity programs, new approvals, US and Southeast Asian sales, and Indian tyre-maker expansions; the new Mundra line was expected to ramp fully in FY20.
Acid contributions expected to face pressure as new North India capacity comes on stream; Oleum demand was described as stable.
Latest events from Oriental Carbon and Chemicals
- COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - FY11 profit rose as capacity expansion targeted strong Insoluble Sulphur demand.OCCL
Q4 10/11 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12